Na Konci Som Dal Info O Serume a Vitamin C Link Pridal Som Aj O Vit C Clanky

Na konci som dal info o serume a Vitamin C link pridal som aj o vit C clanky

How do you stop Ebola in the U.S.?( na HSI )

That's easy. Take everything that our boneheaded government is doing… or claims to be doing… and toss it right out the window. Because it's clear that our public health officials are like the guy who invests in a million-dollar home security system -- and then leaves a house key under the doormat.
Last week, the feds practically rolled out a marching band to announce that five U.S. airports started screening passengers who arrive from West African countries where Ebola is raging.
They proudly beat on their chests while declaring that these five international hubs handle 94 percent of arrivals from affected nations.
Well, guess what, los federales? Not anymore.
It's bad enough that our government -- by its own admission -- instituted a plan that will let 6 percent of West African visitors arrive in America unscreened. But can you think of anything more irresponsible than actually ANNOUNCING which airports would have screening and which wouldn't?
It looks like the next West African who wants to come to America for medical care may have to suffer the indignity of arriving in Baltimore instead of Washington, DC.
But don't worry -- our hospitals are more than ready to handle any Ebola cases that wash up on our shores, right? Er, not exactly.
Time magazine just reported that more than 80 percent of U.S. nurses have received ZERO training in reacting to an Ebola diagnosis in their hospitals.
That's not the same tune the Centers for Disease Control and Prevention has been singing, is it?
I'm sure you've heard how a nurse and a second medical worker in Dallas contracted Ebola from the patient who died there recently. Apparently Patient Number One wasn't quickly isolated and came into contact with other patients.
Was protocol ignored? As one nurse admitted, "There was no protocol."
The survey of nurses reported by Time paints a grim picture. In a huge majority of hospitals there's NO special training, NO procedure in place to identify possible Ebola victims, and NO guidelines about what to do if Ebola is suspected. Supplies such as Hazmat suits, protective eyeware, and impermeable gowns are lacking or nonexistent.
That's how this disease spread like wildfire in the first place. They weren't ready, so they ended up chasing it rather than stomping it out before it started.
This is not a case of hysterical panic -- this is real, my friend! If someone doesn't step up and lead (hint, strangely silent, Mr. Obama) we're going to have some more tragic outcomes on our hands, starting in Dallas and ending who knows where?
What can you do to protect yourself? You'll never hear this from the CDC, the NIH, or the FDA, but you can go here to find out the one important life-saving step that will protect you and your family if -- God forbid -- this horrible disease happens to land anywhere near your neighborhood.

Ebola can’t be treated with drugs, but a nutritional intervention can work

How do you stop Ebola dead in its tracks?

Have you come down with Ebola mania?

I don’t mean actual Ebola, of course. I mean are you suffering from the FEAR of an Ebola pandemic wiping out millions worldwide? If those designed-to-shock Ebola headlines have you feeling jumpy, let me ease your worries. You have a better chance of scoring the winning touchdown in the Super Bowl than of picking up the Ebola virus. So there’s no cause for concern for you or your family. Even so, the mainstream medical crowd can’t help but ratchet up the fear factor. Read any article in the mainstream press and the chatter is the same: No drug! No vaccine! No treatment! No cure! But as usual, these guys simply haven’t done their homework. There IS a treatment that can cure Ebola. It’s intravenous vitamin C, also known as IVC or IAA (intravenous ascorbic acid). Robert Cathcart, M.D., is one of the pioneers of IVC. He’s used IVC to treat thousands of patients with a wide variety of health issues. On his website, he explains that the most serious infectious diseases quickly exhaust all the body’s vitamin C. This causes acute scurvy. So it’s no coincidence that the primary symptoms of Ebola parallel scurvy symptoms: appetite loss, fever, and diarrhea. Then free radicals rage out of control until hemorrhaging causes death. If Ebola is caught early, Dr. Cathcart says that “at least” 180 grams of IVC every 24 hours will eventually control symptoms, bring down fever, and the patient will survive to tell the tale. No need for a vaccine. No need for drugs. In fact, IVC can trounce ALL bacterial and viral infections — including the so-called “superbugs” that antibiotic drugs can’t touch anymore. But the medical establishment has turned its back on this remarkable treatment simply because it’s not a drug. This is nothing new, of course. Dr. Wright has revealed countless nutritional solutions that work wonders compared to drugs. Yet he’s forced to spend has to his days wondering if the FDA is about to burst through his clinic doors, guns drawn — again! (Yes, this actually happened. Read the complete blow-by-blow at this link.) The powers-that-be are locked into Big Pharma’s version of “care” at the expense of effectively treating patients. And, tragically, people are paying the ultimate price. If Ebola should somehow find a foothold here in our homeland, you’ll know what to do. Find a holistic doctor to prescribe IVC — the most effective viral buster that money can buy. Sources: Ebola and Marburg Virus (vitamincfoundation.org) - See more at:

Dasi clanok na Ebolu:

Ebola - Does This Super-Virus Cause a Super-Vitamin C Deficiency?

Vitamin C experts such as Dr. Robert Cathcart, III, MD and Dr. Thomas E Levy, MD, JD have published their ideas for treating the Ebola virus with high dosages of Vitamin C. They have noted that the symptoms of the Ebola virus are similar to a very rapid and powerful scurvy (i.e. a super-vitamin C defiency). Even if this isn't the primary action of the virus, the effect is the same because any powerful viral infection will deplete ascorbate tissues stores per Dr. Cathcart's Titrating Vitamin C to Bowel Tolerance finding. The sicker a person is, the more vitamin C they can tolerate without diarrhea.

It may very well be that large Bowel Tolerance dosages of vitamin C against Ebola are too little too late. Instead, we recommend the even higher Russel Jaffe, PhD, Vitamin C Calibration/Cleanse protocol. In case of suspected Ebola we recommend the following Jaffe protocol.

Jaffe Cleanse:

1. Setup: Determine the largest single dosage that will not cause diarrhea. (This step must be done ahead of time, i.e. right now, if you are not a regular vitamin C "mega" doser.) The one-time dosage is usually 4 to 12 grams.
2. Cleanse: Take the one-time maximum dosage every 15 minutes until the watery discharge which usually occurs around the two hour mark.

Note: When you are well, you can use Dr. Jaffe's Calibration procedure to help you estimate how much vitamin C you should be taking daily. The optimal daily amount is usually put at 75% of your two-hour calibration.

Dr. Thomas Levy believes, based on his clinical observations, that highly encapsulated liposomal vitamin C may exceed intravenous vitamin C clinically by a factor of 10! The Foundation now calls this the Levy Amplification Effect.

• Can Vitamin C Cure Ebola? (Steve Hickey, Hilary Roberts and Damien Downing)
• Cathcart's Bowel Tolerance Paper (PDF)
• Cathcart's Ebola Page
• Levy's Ebola Article
• Russel Jaffe Scientist of the Year (Forum Discussion)
• Foundation's Forum Ebola VirusDiscussion

Experimental Ebola Serum Grown in Tobacco Leaves

Save This Article For Later

Why do I need to register or sign in for WebMD to save?

We will provide you with a dropdown of all your saved articles when you are registered and signed in.

Share this:

Font size:

AAA

By Brenda Goodman, MA
WebMD Health News

Reviewed by Michael W. Smith, MD

Aug. 4, 2014 -- ZMapp, the experimental treatment rushed to two Americans infected with Ebola in Africa, is grown in specially modified leaves of tobacco -- a plant better known for harming health than healing.

“We complied with a request from Emory University and Samaritan’s Purse to provide a very limited amount of ZMapp last week,” says David Howard, a spokesman for Reynolds American Services, the parent company of Kentucky BioProcessing. The small biopharma company in Owensboro, KY, has been contracted to grow the drug.

Ebola Coverage on WebMD
FAQ: The Deadly Ebola Virus
Video: How Ebola Kills
Ebola: How Infectious is It?
Video: CDC on How to Contain Ebola
Experimental Ebola Serum
Ebola: Are Treatments, Vaccines on the Horizon?

Making the serum is slow, in part, because the plants must be grown for several weeks before they are “infected” with a type of protein. “Basically the plants act like a photocopier of the proteins,” Howard says.

Once they’re infected, Howard says it takes a week for the plants to make enough of the protein to harvest and distill into a useable drug.

“Talk about transforming tobacco,” Howard says.

Serum Hadn't Been Used in Humans Before

Based on the interest in the serum, Howard says Kentucky BioProcessing is actively working on ways to scale up its production.

But before it can be used on a wider scale, it must first go through the formal drug approval process with the FDA. Howard says the plan was to begin that process later this year.

The compound used to treat Dr. Kent Brantly and Nancy Writebol was only formulated in January, according to Larry Zeitlin, PhD, president of Mapp Biopharmaceuticals, the California company that co-developed the drug.

It has been tested in monkeys, but had never before been given to human patients before it was rushed to Brantly and Writebol.

Zeitlin says he hasn’t even had a chance to publish a scientific paper on the compound, which is a combination of three antibodies that are thought to help in two ways.

One of the antibodies alerts the immune system to infected cells so they can be destroyed, says Erica Ollmann Saphire, Ph.D. She's a professor of immunology at the Scripps Research Institute in La Jolla, CA. She’s been given a government grant to study the antibody cocktail.

Saphire says the other two antibodies probably prevent the virus from making more copies of itself. “We’re still trying to figure out exactly how it works,” she says. “But it seems to neutralize the virus.”

Cautious Optimism

Other experts who study Ebola urged caution with reports of Dr. Brantly’s dramatic recovery on the drug.

Thomas Geisbert, MD, professor of infectious disease at The University of Texas Galveston Medical Branch, has been studying the Ebola virus since 1988.

Cautious Optimism continued...

He says news accounts that Brantley’srash disappearedin just an hour after receiving a dose of the drug don’t make sense to him.

“When I look at a monkey that has a rash from hemorrhagic fever, small blood vessels have already ruptured,” Geisbert says. “It takes some time for the skin to recover.”

He says other news accounts have stated that Brantly also received blood from a patient who recovered from the infection. That blood might have had protective factors in it.

He says that makes it hard to sort out what might have helped.

“If we can prove that whatever the treatment was worked, that’s fantastic,” he says. “That’s exciting. But I’m cautiously optimistic, because with this particular outbreak, almost 40 percent of patients survive without treatment. So we want to make sure that it wasn’t somebody that was going to survive anyway."

But Saphire says the accounts of Brantly’s speedy turnaround seem plausible to her.

“It hasn’t been used in humans before, so we didn’t know what would happen,” Saphire says. “But antibodies in general can be very effective.”

“I was worried, because in the studies in monkeys, you can save all of them if you treat within 24 hours. If you wait several days for disease to develop, you save half,” she says. She adds that researchers had their fingers crossed that it wouldn’t be too late for Brantly and Writebol, who had been infected for days before they received their doses.

But she says that in the animal experiments, the monkeys were given very high doses of the virus, which may have made it harder to treat.

She says she doesn’t know how that would compare to health care workers infected in a clinic setting.

Saphire says she expects the first human trials of ZMapp to begin in 2015.

Further Reading:

• Slideshow: Ebola Virus Pictures: A Visual Guide
• Quiz: Ebola Facts: Test Your Knowledge
• Ebola Virus: Symptoms, Treatment, and Prevention
• CDC Director Tom Frieden, MD, on Ebola
• Ebola Vaccine Trials
• FDA Update on Ebola
• How Ebola Kills
• See All Ebola Virus Topics

Vitamin C, Titrating to Tolerance

------

----- Robert F. Cathcart,M.D. -----

--- Allergy, Environmental, and ---

----- Orthomolecular Medicine -----

------Orthopedic Medicine ------

--- 127 Second Street, Suite 4 ---

--- Los Altos, California, USA ---

------Fax:650-949-5083 ------

------

Copyright (C), 1994 and prior years, Robert F. Cathcart, M.D. Permission granted to distribute via the internet as long as material is distributed in its entirity and not modified.

Medical Hypotheses, 7:1359-1376, 1981.

VITAMIN C, TITRATING TO BOWEL TOLERANCE, ANASCORBEMIA, AND ACUTE INDUCED SCURVY

Robert F. Cathcart, III, M.D. Allergy, Environmental, and Orthomolecular Medicine 127 Second Street, Los Altos, California 94022, USA Telephone 650-949-2822

ABSTRACT

A method of utilizing vitamin C in amounts just short of the doses which produce diarrhea is described (TITRATING TO BOWEL TOLERANCE). The amount of oral ascorbic acid tolerated by a patient without producing diarrhea increases somewhat proportionately to the stress or toxicity of his disease. Bowel tolerance doses of ascorbic acid ameliorate the acute symptoms of many diseases. Lesser doses often have little effect on acute symptoms but assist the body in handling the stress of disease and may reduce the morbidity of the disease. However, if doses of ascorbate are not provided to satisfy this potential draw on the nutrient, first local tissues involved in the disease, then the blood, and then the body in general become deplete of ascorbate (ANASCORBEMIA and ACUTE INDUCED SCURVY). The patient is thereby put at risk for complications of metabolic processes known to be dependent upon ascorbate.

INTRODUCTION

Over the past ten-year period I have treated over 9,000 patients with large doses of vitamin C (Cathcart 1, 2, 3, 4, 5). The effects of this substance when used in adequate amounts markedly alters the course of many diseases. Stressful conditions of any kind greatly increase utilization of vitamin C. Ascorbate excreted in the urine drops markedly with stresses of any magnitude unless vitamin C is provided in large amounts. However, a more convenient and clinically useful measure of ascorbate need and presumably utilization is the BOWEL TOLERANCE. The amount of ascorbic acid which can be taken orally without causing diarrhea when a person is ill sometimes is over ten times the amount he would tolerate if well. This increased bowel tolerance phenomenon serves not only to indicate the amount which should be taken but indicates the unsuspected and astonishing magnitude of the potential use that the body has for ascorbate under stressful conditions.

If this massive draw on the small ascorbate stores of the body is not fully satisfied, the condition of ANASCORBEMIA results. The deficit of ascorbate probably starts in the tissues directly involved in the disease and then spreads to other tissues of the body. A condition of localized and then systemic acute scurvy is produced. This ACUTE INDUCED SCURVY leads to poor healing and ultimately to complications involving other systems of the body.

Much of the original work with large amounts of vitamin C was done by Fred R. Klenner, M.D. (6, 7, 8, 9) of Reidsville, North Carolina. Klenner found that viral diseases could be cured by intravenous sodium ascorbate in amounts up to 200 grams per 24 hours. Irwin Stone (10, 11, 12) pointed out the potential of vitamin C in the treatment of many diseases, the inability of humans to synthesize ascorbate, and the resultant condition hypoascorbemia. Linus Pauling (13, 14) reviewed the literature on vitamin C and has led the crusade to make known its medical uses to the public and the medical profession. Ewan Cameron in association with Pauling (15, 16, 17) has shown the usefulness of ascorbate in the treatment of cancer.

BOWEL TOLERANCE METHOD

In 1970, I discovered that the sicker a patient was, the more ascorbic acid he would tolerate by mouth before diarrhea was produced. At least 80% of adult patients will tolerate 10 to 15 grams of ascorbic acid fine crystals in 1/2 cup water divided into 4 doses per 24 hours without having diarrhea. The astonishing finding was that all patients, tolerant of ascorbic acid, can take greater amounts of the substance orally without having diarrhea when ill or under stress. This increased tolerance is somewhat proportional to the toxicity of the disease being treated. Tolerance is increased some by stress (e.g., anxiety, exercise, heat, cold, etc.)(see FIGURE I). Admittedly, increasing the frequency of doses increases tolerance perhaps to half again as much, but the tolerances of sometimes over 200 grams per 24 hours were totally unexpected. Representative doses taken by tolerant patients titrating their ascorbic acid intake between the relief of most symptoms and the production of diarrhea were as follows: